Mycobacteriology Unit, National Tuberculosis Reference Laboratory, Centre Pasteur du Cameroun, P.O. 1274, Yaoundé, Cameroon.
Epidemiology and Public Health Unit, Centre Pasteur du Cameroun, Yaoundé, Cameroon.
BMC Infect Dis. 2022 Mar 4;22(1):219. doi: 10.1186/s12879-022-07157-0.
Active tuberculosis (TB) case finding is important as it helps detect pulmonary TB cases missed by the other active screening methods. It requires periodic mass screening in risk population groups such as prisoners and refugees. Unfortunately, in these risk population groups periodic mass screening can be challenging due to lengthy turnaround time (TAT), cost and implementation constraints. The aim of this study was to evaluate a diagnostic algorithm that can reduce the TAT and cost for TB and Rifampicin resistance (RR) detection. The algorithm involves testing with TB-LAMP followed by Xpert MTB/RIF for positive TB-LAMP cases to diagnose TB during mass campaigns in prisons and refugee camps.
The National Tuberculosis Control Program (NTCP) organized routine TB mass-screening campaigns in 34 prisons and 3 villages with refugees camps in Cameroon in 2019. TB LAMP was used for initial TB diagnosis and all TB-LAMP positive cases tested with the Xpert MTB/RIF assay to determine RR. TAT and cost benefits analysis of the combined use of TB-LAMP and Xpert MTB/RIF assays was determined and compared to the Xpert MTB/RIF assay when used only.
A total of 4075 sputum samples were collected from TB presumptive, 3672 cases in 34 prisons and 403 samples in 3 villages. Of the 4,075 samples screened with TB-LAMP, 135 were TB positive (3.31%) and run on the Xpert MTB/RIF. Of the 135 positives cases, Xpert MTB/RIF revealed 3 were RR (2.22%). The use of TB-LAMP followed by testing with Xpert MTB/RIF for TB and RR detection reduced the TAT by 73.23% in prisons and 74.92% in villages. In addition to a reduced TAT, the two molecular tests used in synergy is cost benefit from year 2 onwards.
This study demonstrates the advantages of a diagnostic algorithm based on an initial testing with TB-LAMP followed by testing with Xpert MTB/RIF for TB diagnosis. This approach improved early and rapid TB detection with an added advantage of providing RR status. The proposed algorithm is effective and less costly from the second year of implementation and should be used by TB control programs.
活动性肺结核(TB)病例发现很重要,因为它有助于发现其他主动筛查方法遗漏的肺结核病例。它需要对囚犯和难民等高危人群进行定期大规模筛查。不幸的是,在这些高危人群中,由于周转时间(TAT)长、成本高和实施限制,定期大规模筛查可能具有挑战性。本研究旨在评估一种诊断算法,该算法可以减少 TB 和利福平耐药(RR)检测的 TAT 和成本。该算法涉及在监狱和难民营中进行大规模运动时,首先进行 TB-LAMP 检测,然后对 TB-LAMP 阳性病例进行 Xpert MTB/RIF 检测,以诊断 TB。
2019 年,国家结核病控制规划(NTCP)在喀麦隆的 34 所监狱和 3 个有难民营的村庄组织了常规 TB 大规模筛查运动。TB-LAMP 用于初步 TB 诊断,所有 TB-LAMP 阳性病例均用 Xpert MTB/RIF 检测以确定 RR。确定了联合使用 TB-LAMP 和 Xpert MTB/RIF 检测的 TAT 和成本效益分析,并与仅使用 Xpert MTB/RIF 检测进行了比较。
从 TB 疑似病例中共采集了 4075 份痰液样本,其中 3672 例来自 34 所监狱,403 例来自 3 个村庄。在接受 TB-LAMP 筛查的 4075 份样本中,有 135 份为 TB 阳性(3.31%),并进行了 Xpert MTB/RIF 检测。在 135 例阳性病例中,Xpert MTB/RIF 显示 3 例为 RR(2.22%)。在监狱中,使用 TB-LAMP 检测,然后用 Xpert MTB/RIF 检测 TB 和 RR,可将 TAT 缩短 73.23%,在村庄中可将 TAT 缩短 74.92%。除了 TAT 缩短外,从第二年开始,两种协同使用的分子检测具有成本效益。
本研究表明,基于初始 TB-LAMP 检测,然后进行 Xpert MTB/RIF 检测的诊断算法具有优势,可提高早期快速 TB 检测,同时提供 RR 状态。拟议的算法从实施的第二年起是有效的,成本效益更高,应被结核病控制规划采用。